InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Henn Matthew R.. Officer active across 1 company, notably Seres Therapeutics, Inc.. Cumulatively, 9 reports have been recorded. Activity tracked since 5 July 2022. The latest transaction was disclosed on 27 October 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
9 of 9 declarations